To apply for approval to conduct a clinical trial in China, submit an application to the National Medical Products Administration (NMPA). Include detailed study protocols, investigator qualifications, and ethical committee approval. Ensure compliance with Chinese regulations and guidelines. Approval typically involves a thorough review process by the NMPA and can be done in 60 days.